Tiliroside protects against diabetic nephropathy in streptozotocin-induced diabetes rats by attenuating oxidative stress and inflammation
These findings suggest Til's potential as a therapeutic agent for DN treatment, highlighting its promise for future drug development.
Authors
- Caiyun Yan (ORCID: https://orcid.org/0000-0003-1305-9530)
- Huifeng Zhang (ORCID: https://orcid.org/0000-0003-4663-7384)
- Hui Li (ORCID: https://orcid.org/0000-0001-6396-4833)
- Yan Shang (ORCID: https://orcid.org/0000-0001-8857-7733)
- Na Liu (ORCID: https://orcid.org/0000-0003-0949-4046)
Institutions
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2024-10-16
- DOI
- https://doi.org/10.4239/wjd.v15.i11.2220
- Citations
- 2
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.72